Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry

PLoS Pathog. 2021 Mar 24;17(3):e1009392. doi: 10.1371/journal.ppat.1009392. eCollection 2021 Mar.

Abstract

Coronavirus interaction with its viral receptor is a primary genetic determinant of host range and tissue tropism. SARS-CoV-2 utilizes ACE2 as the receptor to enter host cell in a species-specific manner. We and others have previously shown that ACE2 orthologs from New World monkey, koala and mouse cannot interact with SARS-CoV-2 to mediate viral entry, and this defect can be restored by humanization of the restrictive residues in New World monkey ACE2. To better understand the genetic determinants behind the ability of ACE2 orthologs to support viral entry, we compared koala and mouse ACE2 sequences with that of human and identified the key residues in koala and mouse ACE2 that restrict viral receptor activity. Humanization of these critical residues rendered both koala and mouse ACE2 capable of binding the spike protein and facilitating viral entry. Our study shed more lights into the genetic determinants of ACE2 as the functional receptor of SARS-CoV-2, which facilitates our understanding of viral entry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • COVID-19 / enzymology*
  • COVID-19 / genetics*
  • COVID-19 / virology
  • Host Specificity
  • Humans
  • Mice / genetics
  • Mice / virology
  • Peptidyl-Dipeptidase A / chemistry
  • Peptidyl-Dipeptidase A / genetics*
  • Peptidyl-Dipeptidase A / metabolism
  • Phascolarctidae / genetics
  • Phascolarctidae / virology
  • Receptors, Virus / genetics*
  • Receptors, Virus / metabolism
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / physiology*
  • Sequence Alignment
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / metabolism
  • Virus Internalization

Substances

  • Receptors, Virus
  • Spike Glycoprotein, Coronavirus
  • Peptidyl-Dipeptidase A

Grants and funding

Beijing Municipal Natural Science Foundation (M21001 to QD); National Natural Science Foundation of China (32070153 to QD;32041005 to RZ); Tsinghua University Initiative Scientific Research Program (2019Z06QCX10 to QD); National Key Research and Development Program of China (2020YFA0707701 to RZ); Project of Novel Coronavirus Research of Fudan University (to Y.X.);Tsinghua-Peking University Center of Life Sciences (045-61020100120 to QD); Development Programs for COVID-19 of Shanghai Science and Technology Commission (20431900401 to RZ); Beijing Advanced Innovation Center for Structure Biology (100300001 to QD); a Boston University/NEIDL Startup fund (to FD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.